PATENT CLAIM ANALYSIS

Application Number: 16150845
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "234200"]

Abstract:
The invention provides a compound of Formula I, Pharmaceutical compositions comprising such compounds and the use of such compounds in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase.

Claim (Index 24):
The method of  claim 23 , wherein radiation is x radiation, gamma radiation or particle radiation.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.65714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14979887', '13435062', '15496318', '14197769', '12207788']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8228510818412191
- 35 USC 102 Novelty (BERT): 0.5413967329500102
- Combined Prediction Score: 0.7947056469520982
- Mean Citation Score: 375.112464
- Max Citation Score: 411.64014
- Similarity Product: 227.3636345918333

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test